- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04376138
Longitudinal Validation of Neurofeedback in Stroke Motor Rehabilitation Through Brain Imaging
December 9, 2024 updated by: Sergi Bermúdez i Badia, Universidade da Madeira
With the main goal of generalising findings into Virtual Reality-Neurofeedback-Motor imagery (VR-NF-MI) system, this project aims to develop a new motor rehabilitation tool, for the upper limb, allied to the use of rising of information and communication technologies (ICT).
By identifying correlations on the neural activity, during motor imagery and through brain imaging (fMRI), with distinct training protocols and feedback, these protocols are developed to create user-specific models that later can be used in NF-MI rehabilitation sessions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Every year millions of people worldwide suffer from stroke, being one of the leading causes of death and longterm disability.
This leads to cognitive and motor impairments, resulting in loss of independence in their daily life together with an additional psychological impact in mood disorders and depression.
Evolving to a chronic condition, stroke requires continuous rehabilitation and therapy.
Personalised Virtual-Reality (VR) approaches have been shown to accelerate the recovery process compared to non-Information and communication technologies (ICT) based interventions.
However, most of these novel VR approaches are suitable only for a reduced subset of patients, generally those with better recovery prognostics and better motor control.
Thus, the idea of training the central nervous system was established, through EEG-based neurofeedback (NF) and motor-imagery (MI).
Although the benefits of MI-NF have been illustrated in a plethora of studies, the reduced ability for stroke patients to use NF does not allow an accurate control, reducing the capabilities of MI-NF systems.
The aim of this project is to develop a novel and more inclusive rehabilitation system with the use of novel ICT technologies, in order to overcome current limitations.
This will be achieved by identifying the neural correlates of motor action during motor imagery through brain imaging (fMRI), and differences in brain activation with different training feedback protocols for formulating user-specific models that will be used later in NF-MI rehabilitation sessions.
This will facilitate the use of neural interfaces to train the central nervous system; specifically, the investigators will develop a personalized EEG-based immersive NF through VR for MI training.
The ultimate goal is to generalize the findings into a VR-NF-MI training paradigm for both admitted and ambulatory patients as well as continued domestic care.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Madeira
-
Funchal, Madeira, Portugal, 9004-514
- Serviço de Saúde da Região Autónoma da Madeira
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- First stroke episode
- More than six months after stroke
- Stroke hemiplegia/hemiparesis, (Fugl Meyer below or equal to 47)
- Capacity to understand and complete simple tasks
- Know how to read and write
- Motivation to participate
Exclusion Criteria:
- Hemi spatial neglect
- Depressive symptoms, moderate to severe
- Presence of other neurological or orthopaedic problems
- Severe eyesight problems
- Claustrophobia
- Presence of ferromagnetic materials
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motor Imagery
A Brain-Computer Interaction (BCI) based intervention while receiving conventional therapy.
Use of motor imagery training, allied with brain-computer interaction, as a solution to promote motor and cognitive gains in stroke survivors.
|
30 minutes intervention that occurs 3 times per week, with a goal of 12 sessions total.
Other Names:
|
|
Active Comparator: Conventional Therapy
Extra Occupational Therapy sessions while receiving conventional therapy.
Use of conventional therapy techniques and tools for motor rehabilitation, following the original therapeutic intervention plan of the participants.
|
30 minutes intervention that occurs 3 times per week, with a goal of 12 sessions total.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from the baseline in the functional magnetic resonance imaging (fMRI)
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
Analyze cortical activation, during motor imagery exercises, and cortical structure.
|
Baseline, Final (4 weeks) and 1 month follow up
|
|
Change from the baseline in the Fugl Meyer Motor Assessment
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
Evaluates the motor function of the affected upper limb.
This section has a maximum score of 66 and changes to a higher score means an evolution on motor recovery.
|
Baseline, Final (4 weeks) and 1 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from the baseline in the electroencephalography (EEG) data
Time Frame: In all 12 sessions for 4 weeks
|
Analyze brain activity during motor imagery training to identify the best EEG features that better correlate with the brain activity in motor areas of each participant using Common Spatial Pattern filters.
Examine different modulation rhythms focusing on Alpha and Beta rhythms, during Motor imagery for each BCI session, aiming to find changes in brain activity, in motor and cognitive areas that are related to motor imagery.
Some feature candidates are, Power, Connectivity and Event-Related Synchronization/Desynchronization (ERS/ERD) maps.
|
In all 12 sessions for 4 weeks
|
|
Change from the baseline in the Kinesthetic and Visual Imagery Questionnaire (KVIQ)
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
Assess the motor imagery capacity of the stroke participants.
The maximum score is 100 and a high score reflects a greater ability to visualize and feel imaginary movements.
|
Baseline, Final (4 weeks) and 1 month follow up
|
|
Change from the baseline in the Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
The screening test used to assess different cognitive domains.
The test has a total of 30 points; the higher the score the lesser the probability of cognitive impairment.
|
Baseline, Final (4 weeks) and 1 month follow up
|
|
Change from the baseline in the Modified Ashworth Scale (MAS)
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
Assess muscle tone during movement, in the elbow joint.
The score is valued from 0 to 4 (0, 1, 1+, 2, 3 and 4), a higher score is related to higher spasticity and muscle tone.
|
Baseline, Final (4 weeks) and 1 month follow up
|
|
Change from the baseline in the Geriatric Depression Scale (GDS)
Time Frame: Baseline, Final (4 weeks) and 1 month follow up
|
Self-report assessment to measure depression symptoms in the elderly.
It has a maximum score of 30 points where a score superior to 21 is indicative of the presence of severe depression.
From 11 to 20 points is indicative of mild depression and a score equal or inferior to 10, to the absence of depression.
|
Baseline, Final (4 weeks) and 1 month follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 17, 2019
Primary Completion (Actual)
December 30, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
April 16, 2020
First Submitted That Met QC Criteria
May 1, 2020
First Posted (Actual)
May 6, 2020
Study Record Updates
Last Update Posted (Actual)
December 13, 2024
Last Update Submitted That Met QC Criteria
December 9, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 031485
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on BCI intervention
-
University of CalgaryVIBRAINT Inc.Not yet recruiting
-
University of SheffieldMedical Research Council; Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La Sapienza; Istituto Superiore di SanitàCompleted
-
University of Texas at AustinWithdrawn
-
Duke-NUS Graduate Medical SchoolInstitute of Mental Health, Singapore; Agency for Science, Technology and ResearchCompletedAttention Deficit Hyperactivity Disorder | Autism Spectrum DisordersSingapore
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La SapienzaCompletedSpinal Cord Injuries | Motor DisordersItaly
-
Oregon Health and Science UniversityCompletedAmyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Multiple System Atrophy | Parkinson's Disease and Parkinsonism | Brain Tumor Adult | Locked-in Syndrome | Brainstem StrokeUnited States
-
Taipei Medical UniversityNational Science and Technology CouncilNot yet recruiting
-
Massachusetts General HospitalBrainCells Inc.CompletedMajor Depressive DisorderUnited States
-
US Department of Veterans AffairsNew York State Department of HealthCompletedALS (Amyotrophic Lateral Sclerosis)United States